Page 127 - Read Online

Page 20 of 20 Vidoni et al. J Cancer Metastasis Treat 2021;7:4 I http://dx.doi.org/10.20517/2394-4722.2020.95

132. Yu Y, Zhang XH, Tian HS, Zhang ZY, Tian YJ. Knockdown of long non-coding RNA HOTAIR increases cisplatin sensitivity in ovarian
cancer by inhibiting cisplatin-induced autophagy. J BUON 2018;23:1396-401.
133. Sun MY, Zhu JY, Zhang CY, et al. Autophagy regulated by lncRNA HOTAIR contributes to the cisplatin-induced resistance in
endometrial cancer cells. Biotechnol Lett 2017;39:1477-84.
134. Chen S, Wu DD, Sang XB, et al. The lncRNA HULC functions as an oncogene by targeting ATG7 and ITGB1 in epithelial ovarian
carcinoma. Cell Death Dis 2017;8:e3118.
135. Frankel LB, Wen J, Lees M, et al. MicroRNA-101 is a potent inhibitor of autophagy. EMBO J 2011;30:4628-41.
136. Tekirdag KA, Korkmaz G, Ozturk DG, Agami R, Gozuacik D. MiR-181A regulates starvation- and rapamycin-induced autophagy
through targeting of ATG5. Autophagy 2013;9:374-85.
137. Tang J, Zhu J, Ye YG, et al. Inhibition LC3B can increase chemosensitivity of ovarian cancer cells. Cancer Cell Int 2019;19:199.
138. He J, Yu JJ, Xu Q, et al. Downregulation of ATG14 by EGR1-MIR152 sensitizes ovarian cancer cells to cisplatin-induced apoptosis by
inhibiting cyto-protective autophagy. Autophagy 2015;11:373-84.
139. Zhang FF, Wang BB, Long HL, et al. Decreased miR-124-3p expression prompted breast cancer cell progression mainly by targeting
beclin-1. Clin Lab 2016;62:1139-45.
140. Meng CD, Liu Y, Shen YN, et al. MicroRNA-26b suppresses autophagy in breast cancer cells by targeting DRAM1 mRNA, and is
downregulated by irradiation. Oncol Lett 2018;15:1435-40.
141. Fan YX, Dai YZ, Wang XL, et al. MiR-18a upregulation enhances autophagy in triple negative cancer cells via inhibiting mTOR
signaling pathway. Eur Rev Med Pharmacol Sci 2016;20:2194-200.
142. Fang Y, Xu CY, Fu Y. MicroRNA-17-5p induces drug resistance and invasion of ovarian carcinoma cells by targeting PTEN signaling. J
Biol Res (Thessalon) 2015;22:12.
143. Zhong SL, Li WJ, Chen ZY, Xu JJ, Zhao JH. MiR-222 and miR-29a contribute to the drug-resistance of breast cancer cells. Gene
2013;531:8-14.
144. Shen HY, Wang DD, Li LP, et al. MiR-222 promotes drug-resistance of breast cancer cells to adriamycin via modulation of PTEN/Akt/
FOXO1 pathway. Gene 2017;596:110-8.
145. Zhuo ZH, Yu HM. MiR-205 inhibits cell growth by targeting AKT-mTOR signaling in progesterone-resistant endometrial cancer Ishikawa
cells. Oncotarget 2017;8:28042-51.
146. Wu JS, Jiang Y, Cao WS, et al. MiR-19 targeting of PTEN mediates butyl benzyl phthalate-induced proliferation in both ER(+) and ER(-)
breast cancer cells. Toxicol Lett 2018;295:124-33.
147. Wang YQ, Zhang XY, Tang W, et al. MiR-130a upregulates mTOR pathway by targeting TSC1 and is transactivated by NF-κB in high-
grade serous ovarian carcinoma. Cell Death Differ 2017;24:2089-100.
148. Soni M, Patel Y, Markoutsa E, et al. Autophagy, cell viability, and chemoresistance are regulated by miR-489 in breast cancer. Mol
Cancer Res 2018;16:1348-60.
149. Wang ZY, Wang N, Liu PX, et al. MicroRNA-25 regulates chemoresistance-associated autophagy in breast cancer cells, a process
modulated by the natural autophagy inducer isoliquiritigenin. Oncotarget 2014;5:7013-26.
150. Vidoni C, Ferraresi A, Secomandi E, Vallino L, Dhanasekaran DN, Isidoro C. Epigenetic targeting of autophagy for cancer prevention and
treatment by natural compounds. Semin Cancer Biol 2020;66:34-44.
151. Stückrath I, Rack B, Janni W, Jäger B, Pantel K, Schwarzenbach H. Aberrant plasma levels of circulating miR-16, miR-107, miR-130a
and miR-146a are associated with lymph node metastasis and receptor status of breast cancer patients. Oncotarget 2015;6:13387-401.
152. Pourhanifeh MH, Vosough M, Mahjoubin-Tehran M, et al. Autophagy-related microRNAs: possible regulatory roles and therapeutic
potential in and gastrointestinal cancers. Pharmacol Res 2020;161:105133.
153. Wu H, Liu TT, Qi JN, Qin CY, Zhu Q. Four autophagy-related lncRNAs predict the prognosis of HCC through coexpression and ceRNA
mechanism. Biomed Res Int 2020;2020:3801748.
154. Xiong H, Ni Z, He J, et al. LncRNA HULC triggers autophagy via stabilizing Sirt1 and attenuates the chemosensitivity of HCC cells.
Oncogene 2017;36:3528-40.
155. Ma BB, Yuan ZB, Zhang L, et al. Long non-coding RNA AC023115.3 suppresses chemoresistance of glioblastoma by reducing
autophagy. Biochim Biophys Acta Mol Cell Res 2017;1864:1393-404.
156. Qi P, Zhou XY, Du X. Circulating long non-coding RNAs in cancer: current status and future perspectives. Mol Cancer 2016;15:39.
157. Sun T. Long noncoding RNAs act as regulators of autophagy in cancer. Pharmacol Res 2018;129:151-5.
158. Bayarmaa B, Wu ZP, Peng J, et al. Association of LncRNA MEG3 polymorphisms with efficacy of neoadjuvant chemotherapy in breast
cancer. BMC Cancer 2019;19:877.
159. Vallino L, Ferraresi A, Vidoni C, et al. Modulation of non-coding RNAs by resveratrol in ovarian cancer cells: In silico analysis and
literature review of the anti-cancer pathways involved. J Tradit Complement Med 2020;10:217-29.